The study was performed to determine whether epidural fentanyl produced segmental sensory changes to electrical stimulation at different frequencies. Eight healthy volunteers received fentanyl 1 @g/kg both intravenously and epidurally in a randomized, doubleblind, cross-over fashion. Perception thresholds and amount of current required to elicit a predetermined level of moderate pain (C,,) at 5,250, and 2000 Hz stimulation were measured at ipsilateral dermatomes C2 and L2 at 0,5,15,30,45, and 60 min after injection. Perceptions to 5,250, and 2000 Hz stimulation were unaffected by either intravenous or epidural fentanyl (P > 0.08). Intravenous fentanyl increased C,, at both 5 and 250 Hz at both dermatomes (P < 0.004) and thus did not produce segmental analgesia. In contrast, epidural fentanyl increased C, only at the L2 dermatome and only at 5 Hz (P = 0.005! We conclude that an epidural bolus of fentanyl results in segmental spinal analgesia to transcutaneous electrical stimulation only at specific frequencies. Furthermore, pain produced by stimulation at 5 Hz may have a different pharmacology than pain produced by 250 Hz stimulation.
The study was performed to determine whether epidural fentanyl produced segmental sensory changes to electrical stimulation at different frequencies. Eight healthy volunteers received fentanyl 1 @g/kg both intravenously and epidurally in a randomized, doubleblind, cross-over fashion. Perception thresholds and amount of current required to elicit a predetermined level of moderate pain (C,,) at 5,250, and 2000 Hz stimulation were measured at ipsilateral dermatomes C2 and L2 at 0,5,15,30,45, and 60 min after injection. Perceptions to 5,250, and 2000 Hz stimulation were unaffected by either intravenous or epidural fentanyl (P > 0.08). Intravenous fentanyl increased C,, at both 5 and 250 Hz at both dermatomes (P < 0.004) and thus did not produce segmental analgesia. In contrast, epidural fentanyl increased C, only at the L2 dermatome and only at 5 Hz (P = 0.005! We conclude that an epidural bolus of fentanyl results in segmental spinal analgesia to transcutaneous electrical stimulation only at specific frequencies. Furthermore, pain produced by stimulation at 5 Hz may have a different pharmacology than pain produced by 250 Hz stimulation. (Anesth Analg 1996; 82:98-102) I t is not clear whether epidural administration of fentanyl results in systemic (1,2) or segmental spinal analgesia (3-5), or both. The use of transcutaneous electrical stimulation may be a way of determining segmental analgesia (5). Furthermore, stimulation at various frequencies may be a useful means to examine different sensory pathways. Lowfrequency stimulation has been correlated with activation of small nerve fibers via thermal thresholds, and higher frequency stimulation has been correlated with predominant activation of large nerve fibers via quantitative vibration testing (6-B). Stimulation at specific frequencies of 5, 250, and 2000 Hz produces subjectively different sensations, and recovery of cutaneous perception to stimulation at these frequencies has been correlated with regression of sensory block to cold, pinprick, and touch after lidocaine spinal anesthesia (9). Thus, this study was designed to determine whether epidural administration of fentanyl would produce segmental sensory changes to perception and Accepted for publication July 28, 1995. Address correspondence to Spencer S. Liu, MD, Department of Anesthesiology, Virginia Mason Center, 1100 Ninth Ave., PO Box 900, Seattle, WA 98111. pain during transcutaneous electrical stimulation at 5, 250, and 2000 Hz.
Methods
After institutional review board approval and informed consent were obtained, eight (five female/ three male) healthy volunteers were studied in a randomized, double-blind, balanced, cross-over fashion. Subjects were initially trained to perceive perception thresholds to transcutaneous constant sine wave electrical currents at 5, 250, and 2000 Hz with a commercially available device (Neurometer@ CPT; Neurotron Incorporated, Baltimore, MD) at the C2 (behind the ear) and L2 (medial aspect of knee) dermatomes on the ipsilateral side as previously described (9). Perception thresholds at each frequency were determined by slowly increasing the current (to a maximum of 9.99 mA) until the subject reported sensation. The current was then shut off, decreased by 0.08 mA, and reapplied. This sequence was repeated, with increasing and decreasing adjustments in current, until a bracket was found where the upper end of the current range was always felt and the lower current intensity was never felt. The middle of this 0.08 mA bracket was using a visual analog pain scale WAS) rated from 0 = no pain to 100 = maximum pain) was reported by the subject. The VAS pain score was shown to the subject before each subsequent measurement of pain, and the subject was instructed to stop each measurement for pain at that same intensity. Thus, pain intensity was standardized for repeated measurements within each subject and for both sessions, but not between subjects. All measurements were measured with the subject blinded to the magnitude of the current.
Each subject was studied at two different sessions separated by at least 48 h. Study sessions were performed in a quiet, unstressful environment at the same location and time of day. At each session, an intravenous (IV) catheter was inserted. Then, subjects were placed in the left lateral decubitus position, the epidural space identified with a l&gauge Tuohy needle via the midline approach at the L2-3 vertebral interspace, and a catheter advanced 3 cm into the epidural space. No systemic medications were administered during IV or epidural catheter placement, and no local anesthetics were injected through the epidural catheters at this time.
After placement of IV and epidural catheters, baseline measurements (0 min) for perception threshold at 5, 250, and 2000 Hz and C,, at 5 and 250 Hz were performed in triplicate and averaged. Then, 1 pg/kg of fentanyl diluted with normal saline to a volume of 10 mL was injected into the epidural catheter at one session and into the IV catheter at the other session. The order of fentanyl injection was randomized, and normal saline (10 mL) was simultaneously injected via the other route to maintain blinding of subject and observer.
Perception thresholds and C,, were measured at the C2 and L2 dermatomes at 5, 15, 30, 45, and 60 min after injections.
Previous studies suggest that repeated measures of current perception are reproducible (9) and such reproducibility was assumed for C,, measurements.
The sequence of measurements was randomized.
After the 60-min measurement, naloxone (400 pg) was administered IV and 5 min later a last set of measurements was obtained. Finally, 45 mg of lidocaine was injected into the epidural catheter and a band of analgesia to pinprick sought for confirmation of correct placement of the epidural catheter. If a band of analgesia did not develop, then data from that subject would be excluded.
Variations in interindividual amounts of current required for C,, were expected, thus amount of current for perception and C,, for each frequency for each measurement period at each dermatome were normalized against the baseline value obtained for each individual using the following formula: (D,/D,) * 100, where D, = measurement at time X, Do = measurement at baseline (0 min). In order to determine whether segmental analgesia had occurred, a ratio of C from dermatome L2/C,, from dermatome C2 wri calculated for each measurement period. Significant increases above baseline values were determined by calculating 95% confidence intervals for mean differences between values obtained at 0 min (baseline) versus all other measurement periods. Differences between IV and epidural administration of fentanyl were analyzed with repeated-measures analysis of variance followed by post hoc testing with Scheffe's F-test. Significance was defined as P < 0.05.
Results
All subjects were ASA class I. Ages ranged from 31 to 46 yr, weights from 50 to 90 kg, and heights from 140 to 166 cm. VAS pain scores for determination of C,, at 5 Hz stimulation was 42 + 2 (mean + SD) and at 250 Hz stimulation was 44 + 4. Data from all subjects were included in analysis.
Effects of IV and Epidural Fentanyl at the Cervical Level
Perception thresholds to 5,250, and 2000 Hz were not significantly changed to dermatome C2 by either epidural or IV fentanyl or IV naloxone. Maximal stimulation (9.99 mA) at 2000 Hz did not cause pain. C,, at 5 and 250 Hz was increased at dermatome C2 after IV fentanyl but unaffected by epidural fentanyl (Fig. 1) . Administration of naloxone returned C,, values to baseline.
Effects of IV and Epidural Fentanyl at the Lumbar Level
Perception thresholds to 5, 250, 2000 Hz were not significantly changed at dermatome L2 by either epidural or IV fentanyl or IV naloxone. Maximal stimulation (9.99 mA) at 2000 Hz again did not cause pain. IV fentanyl increased C,, at both 5 and 250 Hz at dermatome L2 but increased 5 Hz stimulation to a lesser degree (P < 0.006) than epidural fentanyl (Fig.  2) . In contrast to effects observed at C2, epidural fentanyl increased C,, only at 5 Hz at L2 (Fig. 2) . Administration of naloxone returned C,, values to baseline.
Segmental Effects of IV and Epidural Fentanyl As IV fentanyl equivalently increased C,, at both 5 and 250 Hz at both C2 and L2, IV fentanyl did not result in an increase of the ratios (L2/C2) of C,, ( 3). In contrast, the ratio of C,, increased only at 5 Hz after epidural administration (Fig. 3) . Administration of IV naloxone returned C,, ratios to baseline.
Discussion
We found that IV administration of fentanyl produced equivalent analgesia to painful electrical stimulation at 5 and 250 Hz at both cervical and lumbar dermatomes, and thus did not produce segmental analgesia. In contrast, epidural administration of fentanyl provided segmental and more intense analgesia only to ~-HZ stimulation. Increases in segmental pain stimulation at 5 Hz dissipated after administration of naloxone, which supports an opioid specific effect (10,ll). Development of segmental, naloxone reversible analgesia after epidural administration of fentanyl provides evidence for opioid specific, spinal analgesia (12). fentanyl provided evidence of spinal analgesia. These studies demonstrated that an epidural bolus provided segmental analgesia (4,5), greater duration of analgesia (14), less respiratory depression (15), and significantly lower blood levels (3,5) when compared with a systemic bolus of fentanyl. In contrast, previous studies comparing epidural versus IV fentanyl administered via constant infusion (1) or via patient-controlled analgesia devices (2) have observed similar pain scores, rates of fentanyl consumption, and systemic blood levels of fentanyl after several hours of administration. Thus, there are probably differences in the analgesic and therapeutic efficacy of bolus epidural fentanyl versus continuous infusion of epidural fentanyl that are perhaps due to the different cerebrospinal fluid and blood levels achieved with each technique.
Our data also suggests potential differences in analgesia after epidural and IV administration of fentanyl. IV fentanyl equally increased C, at 5 and 250 Hz, whereas epidural fentanyl primari y increased the .P amount of current required to elicit moderate pain at 5 Hz. This difference between epidural and IV fentanyl may indicate difference analgesic actions between the two routes of administration.
The concept of different analgesic pathways in humans after central neuraxial versus systemic administration of opioids would be consistent with animal studies. For examples, spinal administration of opioids produces analgesia primarily by modulating C fiber nociception at the spinal cord (16-18). On the other hand, systemic opioids may provide analgesia through several different pathways. For example, binding of systemically administered opioid to supraspinal opioid receptors can directly produce analgesia or indirectly modulate analgesia through inhibition of nociceptive input from the spinal cord (19). Furthermore, systemic opioids may also produce analgesia through nonopioid analgesic pathways such as adrenergic (20) and histaminemediated pathways (21). Finally, the combined effects of spinal and systemic opioids result in profound analgesic synergism (22,23) which further suggests activation of different analgesic pathways. Although our data do not allow insight into molecular or mechanistic differences between analgesic pathways of systemic and spinal opioids, they suggest that such differences may exist in humans.
There are several limitations to this study. A relatively small and arbitrarily chosen number of subjects were studied which increases the likelihood of Types 1 and 2 statistical errors. Subjects were studied for only 1 h and only after a single dose of fentanyl. A longer period of study or a larger dose of epidural fentanyl may have demonstrated dose and time dependence of segmental analgesia due to systemic absorption (5) and cephalad spread of fentanyl in the cerebral spinal fluid (3). The use of transcutaneous electrical current to "selectively" stimulate different nerve populations has been inferred only indirectly via correlation with thermal thresholds (small fibers) and quantitative vibration testing (large fibers) (6,B). The frequencies used for "selective" stimulation by the Neurometerm device (5, 250, and 2000 Hz) were empirically determined, and direct confirmation with single nerve fiber recordings has not been undertaken in humans. In addition, previous investigators have suggested that transcutaneous electrical stimulation may activate low threshold cutaneous mechanoreceptors rather than individual nerve fibers (6). Thus, our results do not provide definitive proof for differential mechanisms of analgesia when fentanyl is administered epidurally versus IV.
In conclusion, our study indicates that single bolus administration of epidural fentanyl can produce segmental spinal analgesia to electrical stimulation. IV and epidural administration of fentanyl produced different analgesic effects to electrical stimulation. This finding may suggest activation of different analgesia pathways after spinal and systemic administration of opioids in humans. 
